EU legislation threatens clinical trialsBMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7403.1348-a (Published 19 June 2003) Cite this as: BMJ 2003;326:1348
- Rory Watson
European Union legislation due to take effect next year could seriously reduce the scope for non-commercial clinical trials, says Cancer Research UK.
The new rules are designed to simplify and harmonise the many different national provisions now in force relating to good practice in the conduct of clinical trials of medicinal products. Their aim is to ensure good care of patients and to make it easier to conduct pan-European research.
But, as governments now prepare the enabling legislation to implement the EU rules in domestic …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial